Virtual reality hypnosis tested to ease chemo anxiety in prostate cancer

NCT ID NCT04533958

First seen Apr 10, 2026 · Last updated May 16, 2026 · Updated 5 times

Summary

This study looked at whether using hypnosis in virtual reality could help reduce anxiety in men with metastatic prostate cancer during their chemotherapy treatments. 53 men receiving a standard chemotherapy drug (docetaxel) were randomly assigned to either get the VR hypnosis or standard care. The goal was to see if the VR hypnosis lowered anxiety and nausea before and after each infusion.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CHP Saint-Grégoire

    Saint-Grégoire, 35760, France

  • Clinique Pasteur-Lanroze

    Brest, 29200, France

  • Clinique de la Côte d'Emeraude

    St-Malo, 35400, France

  • Hospital Lusiadas Amadora

    Amadora, 2724-002, Portugal

  • Hospital Lusiadas Lisboa

    Lisbon, 1500-458, Portugal

  • Hospital Lusiadas Porto

    Porto, 4050-115, Portugal

Conditions

Explore the condition pages connected to this study.